ELOVL5 调节乳腺癌细胞中的铁亡
K V Klycheva1, A V Razumovskaya2, A D Shatsillo1
1Faculty of Biology and Biotechnology, National Research University "Higher School of Economics", Moscow, Russia.
Doklady. Biochemistry and biophysics
|December 2, 2025
概括
减少ELOVL5基因表达增强了乳腺癌细胞对细胞死亡途径铁亡的敏感性. 这一发现为向乳腺癌治疗提供了新的途径.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞死亡研究 细胞死亡研究
背景情况:
- 乳腺癌 (BC) 是全球癌症死亡的主要原因.
- 铁亡,一种独特的细胞死亡形式,显示出治疗BC抗常规疗法治疗的希望.
- 对于脂肪酸延长至关重要的ELOVL5基因与BC进展有关.
研究的目的:
- 研究ELOVL5基因淘汰对MDA-MB-231乳腺癌细胞中铁灭诱导的影响.
- 为了分析基因表达变化在多可沙赫萨酸 (DHA) 和erastin的影响下.
- 探索ELOVL5在调节ferroptosis中的作用,用于潜在的向BC疗法.
主要方法:
- 在MDA-MB-231细胞中利用ELOVL5基因敲除.
- 服用多可沙赫萨酸 (DHA) 和埃拉斯来诱导铁亡.
- 使用铁灭菌抑制剂 (ferrostatin-1,deferoxamine) 来验证途径的参与.
- 进行了对基因表达的比较分析.
主要成果:
- 减少ELOVL5表达显著增加了MDA-MB-231细胞对铁亡的敏感性.
- 与erastin相比,多可沙赫萨酸 (DHA) 诱导了较早的细胞死亡.
- 铁灭抑制剂证实了该途径在观察到的影响中的作用.
- 确定了与氧化应激,炎症和增殖相关的独特基因表达模式,这表明了不同的铁灭机制.
结论:
- ELOVL5基因表达极大地影响了乳腺癌细胞对铁亡的敏感性.
- 向ELOVL5可能会提高诱导铁亡的药物在乳腺癌治疗中的疗效.
- 这项研究提供了对ELOVL5在ferroptosis中的调节作用的更深入的见解,为新的治疗策略铺平了道路.
相关概念视频
Necrosis
6.2K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
6.2K
Regulation of the Unfolded Protein Response
2.9K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.9K
Regulation of Nuclear Protein Sorting
3.2K
Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
3.2K
mTOR Signaling and Cancer Progression
4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.6K
The Early Endosome: Endocytosis of Transferrin
4.6K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.6K
Regulation of Angiogenesis and Blood Supply
3.3K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K
